ISPOR - Trends in the Economic Value of Newly Approved Cancer Therapies in the U.S

Full Text

Trends in the Economic Value of Newly Approved Cancer Therapies in the U.S

Abstract

Authors

AJ Chen X Hu AB Jena DP Goldman

Back to Volume 21, Supplemental S1

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now